Memory loss in Alzheimer’s disease may be preceded by structural changes in the brain up to a decade before clinical symptoms appear, according to a study published in NeuroImage: Reports.
Researchers found that the entorhinal cortex and the amygdala shrink faster than the hippocampus in the early stages of the disease. While clinical evaluations routinely focus on the hippocampus as the primary memory center, these neighboring regions show accelerated volume loss earlier in older adults.
Senior author Michael Miller, a biomedical engineer at Johns Hopkins University, said that the slow loss of brain cells can be detected on imaging up to 10 years before a person exhibits symptoms, according to Goldring. He noted the potential to intervene when neurodegenerative changes emerge years earlier rather than waiting until memory symptoms manifest decades later.
The analysis relied on hundreds of magnetic resonance imaging and positron emission tomography scans from the Alzheimer’s Disease Neuroimaging Initiative and the BIOCARD study. These projects included individuals with typical memory function alongside those experiencing mild cognitive impairment or Alzheimer’s dementia.
To track tissue loss, two researchers manually outlined the amygdala and entorhinal cortex on 665 scans with guidance from a neuroanatomist. A deep learning program subsequently mapped these regions across the broader dataset to calculate annual volume reduction.

Among participants in the BIOCARD project with mild cognitive impairment or dementia, the hippocampus lost 0.76% of its volume annually. By comparison, the amygdala lost 2.38% per year, and the entorhinal cortex lost 3.69% annually.
In the larger multi-site initiative, tissue loss occurred at even higher rates across diagnostic groups. The hippocampus in the Alzheimer’s group lost 3.23% of its volume per year, while the amygdala decreased by 7.19% and the entorhinal cortex declined by 8.40% annually.
Volunteers with typical memory function demonstrated the same pattern at slower rates. In the larger cohort, the entorhinal cortex lost 1.84% annually, increasing to 3.53% among those with mild cognitive impairment and reaching 8.40% in participants with Alzheimer’s disease.
Abnormal tau protein accumulation contributes to the structural decline observed in the brain scans. In Alzheimer’s disease, tau forms tangles inside nerve cells, disrupting their stability and function.
PET imaging showed that regions with stronger tau signals also experienced more rapid volume loss. Within the amygdala, tissue deterioration was uneven, with subregions near the center of the brain shrinking by up to 8.31% annually, while the external subregion declined at a slower rate.
Researchers emphasized that identifying individuals at risk of cognitive decline will become increasingly critical as targeted treatments emerge. Statistical models tested by the team demonstrated that incorporating measurements from the entorhinal cortex and amygdala alongside the hippocampus moderately improved the ability to distinguish healthy individuals from those in early stages of cognitive impairment.
Research suggests these regions may begin to shrink up to a decade before clinical memory loss becomes apparent. The study utilized scans from volunteers whose average ages ranged from roughly 68 to 74 years old.
Data across the analyzed cohorts show that the entorhinal cortex and amygdala shrink at faster annual percentages than the hippocampus in both healthy older adults and those with cognitive impairment.
The findings do not yet establish a precise timeline for the onset of tissue reduction and cannot be used alone as a standalone diagnostic tool. Researchers note that monitoring these regions may eventually help identify individuals at risk before clinical symptoms emerge.
Worth a look